Most Favored Nation (MFN) type drug pricing proposals that were proposed by the Centers for Medicare & Medicaid Innovation (CMMI) in December 2025 would […]
BIO Coffee Chat: MFN proposals would harm innovation and access Read More »
Maintaining a world-leading biotech industry keeps Americans safer and its economy stronger. Appropriate federal actions can support this leadership, the Biotechnology Innovation Organization (BIO)
BIO tells Congress how to maintain US biotech leadership Read More »
In an initiative to accelerate capital formation for biotech innovation, the Biotechnology Innovation Organization (BIO) on Jan. 7 launched the BIO Investment Council (BIC),
BIO Investment Council will bring together VC and small biotechs to boost innovation Read More »
Patient advocates retold emotional stories of lives saved, changed—or at risk—as they discussed one of the most important factors enabling breakthroughs in fighting rare
Patient advocates urge action on PPRV to help fight rare disease Read More »
When it comes to enabling new treatments for type 1 diabetes (T1D), Breakthrough T1D is an outstanding example of a patient group driving research
Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation Read More »
Cancer patients are suffering serious health consequences because step therapy practices enforced by pharmacy benefit managers (PBMs) are preventing timely access to essential medicines,
Oncologist warns PBM step therapy has ‘crossed a dangerous line’ Read More »
The rapidly growing biotech ecosystem supporting innovation in Texas received national attention during a visit by the Biotechnology Innovation Organization (BIO) on Sept. 15-16.
BIO on the American Road: Everything’s big in Texas, including biotech Read More »
At this year’s BIO International Convention in Boston, Riboway Therapeutics emerged as the winner of the 2025 BIO Start-Up Stadium seed-stage category. For founder and
Riboway Therapeutics: Resilience, RNA, and redefining the undruggable Read More »
As drug makers work to develop safe, effective gene therapies, their progress can be slowed when they challenge the limits of established regulatory guidance
George W. Bush, 43rd President of the United States, headlined Tuesday’s mainstage with an exclusive conversation with Biotechnology Innovation Organization (BIO) President & CEO
BIO 2025: A few highlights from Day 2 Read More »
